Connect with us

Headlines

89-Location Optometry Network Acquired

It operates in Arizona and Florida.

mm

Published

on

ST. LOUIS – EyeCare Partners LLC, a network of medical optometry and ophthalmology practices, announced that it has completed the acquisition of Nationwide Vision, a full-service vision care provider.

Financial terms of the deal were not disclosed.

The acquisition “continues to strengthen ECP’s network of free-standing optometric offices in fast-growing regional markets,” according to a press release.

Nationwide, headquartered in Chandler, AZ, operates 89 optometry offices throughout Arizona and Florida offering eyecare services and eyewear products. The company has over 780 employees, including full-time optometrists who perform more than 250,000 comprehensive exams annually.

“Nationwide is exceptionally well respected in Arizona and Florida, where its premier eye health services, consistent value and broad assortment of fashionable eyewear are experiencing strong demand from existing and new customers,” said Kelly McCrann, CEO of ECP. “We are thrilled Nationwide’s entire team, and especially its leader Al Bernstein, has joined ECP. We look forward to leveraging Nationwide’s deep experience with managed vision plans to help expand ECP into new markets.”

Bernstein said, “All of us at Nationwide Vision are excited about our opportunity to partner with EyeCare Partners. ECP has a reputation for being a superb business partner and we are eager to leverage its capabilities to pursue expansive growth in Arizona and Florida, two of the fastest-growing markets in the U.S.”
With 12 optometric and ophthalmic acquisitions in 2019, ECP now operates across 12 states throughout the Midwest, Southeast and Mid-Atlantic regions, as well as the Southwest with the addition of Nationwide. ECP supports the growth of its practices with revenue cycle management, purchasing, marketing, human resources, recruiting, training, IT and other business functions.

Advertisement

“With the Nationwide team, we look forward to providing patients with the ultimate in eye care in
Arizona and Florida,“ said Dr. James J. Wachter, chief professional officer of ECP.

Since launching in 2014, INVISION has won 23 international journalism awards for its publication and website. Contact INVISION's editors at editor@invisionmag.com.

Advertisement

SPONSORED VIDEO

SPONSORED BY REICHERT

When You’re Passionate About Eye Care, the Right Technology Matters

Lisa Genovese, O.D., strives to give her patients the very best. At Insight Eye Care’s multiple locations, Dr. Genovese provides optimal care for her patients using the Reichert® Phoroptor® VRx Digital Refraction System. In this second Practice Profile Video from Reichert’s “Passionate About Eye Care” series, take a closer look and see how this eye care professional achieved a better work-life balance with equipment that’s designed and engineered in the U.S.A.

Promoted Headlines

Headlines

Japanese Women Seek Right to Wear Eyeglasses at Work

Some companies require female workers to wear contacts instead.

mm

Published

on

Women in Japan are calling for an end to company policies that forbid them from wearing eyeglasses, Fortune reports.

The issue appeared in the news recently, with Nippon TV reporting on companies that have such a ban in place, requiring female employees who need vision correction to wear contact lenses instead. That report sparked the hashtag “glasses ban” on Twitter.

Fortune quoted Banri Yanagi, a 40-year-old sales associate in Tokyo, saying, “The emphasis on appearance is often on young women and wanting them to look feminine.”

Yanagi added that it’s “strange” to prohibit eyeglasses for women but allow them for men.

Employees have also rallied against requirements at some companies for women to wear makeup and/or high heels.

Read more at the Fortune

Continue Reading

Headlines

Eye Health Firm Plans Job Cuts

It will focus resources on Dextenza.

mm

Published

on

BEDFORD, MA — Ocular Therapeutix Inc., a biopharmaceutical company focused on therapies for eye conditions and diseases, announced an operational restructuring plan.

The plan is expected to result in about $11 million in annualized savings through personnel reductions and $14 million in “one-time program deferrals,” according to a press release. The company did not say how many jobs would be cut.

With the restructuring, the company is looking to focus resources on Dextenza, an FDA-approved corticosteroid indicated for the treatment of ocular inflammation and pain following ophthalmic surgery.

“We have elected to restructure Ocular in order to maximize the opportunity we have with DEXTENZA and our pipeline,” said Antony Mattessich, president and CEO. “We will use a portion of the savings generated to increase the size of our commercial field force to broaden our national reach and increase DEXTENZA promotional capabilities. Additionally, the savings are anticipated to extend our cash runway through the end of 2020 and provide an improved financial position as we build the Company for the long term.”

According to the press release:

The restructuring represents a strategic realignment and commitment by the Company to allocate capital and resources to maximize the commercial opportunity of DEXTENZA® and focus resources on progressing key pipeline assets, including completion of its DEXTENZA Phase 3 trial in allergic conjunctivitis and completion of Phase 1 trials of OTX-TIC for the treatment of glaucoma and ocular hypertension and OTX-TKI for the treatment of wet age-related macular degeneration. The Company believes the savings, combined with projected sales of DEXTENZA and cash and cash equivalents, will result in an extension of the Company’s current cash runway through the fourth quarter of 2020.

Continue Reading

Headlines

FTC Releases Disclosures Guidance for Social Media Influencers

It explains when and how influencers must disclose sponsorships to their followers.

mm

Published

on

Enlisting social media “influencers” has become a popular way to promote a wide range of products, including eyewear.

Unfortunately, it’s not always obvious to consumers what is and isn’t an ad. The Federal Trade Commission wants to fix that.

The FTC has released a new publication for online influencers that lays out the agency’s rules of the road for when and how influencers must disclose sponsorships to their followers.

The new guide, “Disclosures 101 for Social Media Influencers,” provides influencers with tips from FTC staff about what triggers the need for a disclosure and offers examples of both effective and ineffective disclosures.

The guide and accompanying videos underscore that the responsibility to make disclosures about endorsements lies with the influencer. The guide outlines the various ways that an influencer’s relationship with a brand would make disclosures necessary, and it reminds influencers that they cannot assume that followers are aware of their connections to brands.

The guide includes tips for when and how influencers should tell their followers about a relationship. For example, it suggests the words influencers might use, as well as where in their social posts a disclosure should appear.

The new publication summarizes the FTC’s existing guidance in this area, including the FTC’s Endorsement Guides and a 2017 question-and-answer document produced by staff.

Continue Reading

Advertisement

Advertisement

Subscribe


BULLETINS

Get the most important news and business ideas for eyecare professionals every weekday from INVISION.

Advertisement

Most Popular